tm logo
MAKE CANCER A BENIGN EXPERIENCE
Live/Registered
REGISTERED

on 23 Jan 2024

Last Applicant/ Owned by

161 Oyster Point Blvd

South San Francisco

CA

94080

Serial Number

90701065 filed on 10th May 2021

Registration Number

7287794 registered on 23rd Jan 2024

in the Principal Register

Correspondent Address

Ted D. Karr

Ted D. Karr

17933 NW EVERGREEN PLACE, SUITE 250

BEAVERTON,OR 97006

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

MAKE CANCER A BENIGN EXPERIENCE

Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer


First Use Date in General

05th Oct 2022

First Use Date in Commerce

05th Oct 2022

Class [005]
Pharmaceutical Products


Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer


First Use Date in General

04th Jan 2023

First Use Date in Commerce

24th Jan 2023

Specimens


MAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimenMAKE CANCER A BENIGN EXPERIENCE specimen

Mark Details


Serial Number

No 90701065

Mark Type

No Service Mark

Attorney Docket Number

No 413.T002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd Jan 2024REGISTERED-PRINCIPAL REGISTER
23rd Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
19th Dec 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
18th Dec 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07th Dec 2023ASSIGNED TO LIE
07th Dec 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
07th Dec 2023TEAS/EMAIL CORRESPONDENCE ENTERED
07th Jul 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
10th Apr 2023SU - NON-FINAL ACTION - WRITTEN
10th Apr 2023NON-FINAL ACTION E-MAILED